Pentwater Capital Management’s Immunomedics Inc IMMU Stock Holding History

Pentwater Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,920,000	Closed	-$333M	–	293
2020 Q3	$333M	Buy	+3,920,000	New	+$198M	4.31%	5

Pentwater Capital Management's IMMU Position: Q4 2020 in Review

Pentwater Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 3,920,000 shares — an estimated $333M sold.

Pentwater Capital Management first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $333M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Pentwater Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Pentwater Capital Management sold 3,920,000 Immunomedics Inc shares in Q4 2020, an estimated $333M.
Pentwater Capital Management first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
Pentwater Capital Management's Immunomedics Inc position peaked at $333M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Pentwater Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.